PEA15 antibody
Principal name
PEA15 antibody
Alternative names for PEA15 antibody
Astrocytic phosphoprotein PEA-15, PED, Phosphoprotein enriched in diabetes
Ncbi ID
NP_003759.1, 9606, NP_003759, NP_001013249.1, NP_035193.1, NM_001013231, NM_003768
Available reactivities
Available hosts
Available applications
Immunocytochemistry/Immunofluorescence (ICC/IF), Western blot / Immunoblot (WB), Paraffin Sections (P), ELISA (detection) (E(detection)), Enzyme Immunoassay (E)
Background of PEA15 antibody
PEA-15 (phosphoprotein enriched in astrocytes) exists in an non-phosphorylated form (N), and two phosphorylated forms, Pa and Pb. PEA-15 is an endogenous substrate for PKC, which mediates the transition from Pa to Pb. The level of PEA-15 phosphorylation changes upon depolymerization or stabilization of tubulins, indicating that PEA-15 co-localizes with microtubules. The first 80 amino acids of PEA-15 correspond to the death effector domain (DED), which is a domain found in proteins that regulate apoptotic signaling pathways. The DED domain is necessary for PEA-15 to block Ras suppression. Although PEA-15 is predominantly expressed in the central nervous system, low levels of PEA-15 are expressed in liver and kidney, and higher levels in muscle. PEA-15 is also referred to as PED, phosphoprotein enriched in diabetes, for its elevated expression in type 2 diabetic patients.
General readings
Beguinot F., et al. (2009) Am J Physiol Endocrinol Metab. 297(3):E592-601.
Ueno NT., et al. (2008) Cancer Res. 68(22):9302-10.













Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA314790 | PEA15 antibody |
||||||
| Rabbit polyclonal anti-PEA-15 antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu, Ms | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA314791 | PEA15 antibody |
||||||
| Rabbit polyclonal PEA-15 (Ser104) antibody(Phospho-specific) | |||||||
![]() |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
+1 additional image |
|||||||
| AP06559PU-N | PEA15 antibody |
||||||
![]() |
Rabbit | Aff - Purified | Hu, Ms, Rt | ICC/IF, P, WB |
0.1 mg /
€370.00
|
||
| OriGene Technologies GmbH | |||||||
+1 additional image |
|||||||
| AP18148PU-N | PEA15 (C-term) antibody |
||||||
![]() |
Rabbit | Hu, Ms | WB |
0.4 ml /
€415.00
|
|||
| OriGene Technologies GmbH | |||||||
| AP55709PU-N | PEA15 pSer104 antibody |
||||||
![]() |
Rabbit | Aff - Purified | Hu, Ms, Rt | P, WB |
0.1 mg /
€300.00
|
||
| OriGene Technologies GmbH | |||||||
+1 additional image |
|||||||
| AP55709PU-S | PEA15 pSer104 antibody |
||||||
![]() |
Rabbit | Aff - Purified | Hu, Ms, Rt | P, WB |
50 µg /
€230.00
|
||
| OriGene Technologies GmbH | |||||||
+1 additional image |
|||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP305507 | PEA15 |
||||
| Recombinant protein of human phosphoprotein enriched in astrocytes 15 (PEA15) | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR204927L2V | Lenti ORF particles, Pea15 (GFP-tagged ORF) - Rat phosphoprotein enriched in astrocytes 15A (Pea15a), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| RR204927L1V | Lenti ORF particles, Pea15 (Myc-DDK-tagged ORF) - Rat phosphoprotein enriched in astrocytes 15A (Pea15a), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
















+1 additional image



